ATS Medical, Inc. (ATSI) recently received CE Mark approval to distribute the ATS 3f Enable Aortic Bioprosthesis in the European Union. The Enable valve is implanted using a sutureless technique. It is the first surgical aortic valve replacement approved for commercial use. The product will be available immediately in a soft launch in the European Union followed by full launch in the second half of 2010.   The Enable valve is designed to achieve a less invasive aortic valve replacement. It has been seen that most aortic valve surgeries cannot be performed on a minimally invasive basis. This is due to the fact that precise suturing is difficult within the confined space of a minimally invasive procedure. ATS Medical’s Enable valve eliminates this handicap.

Furthermore, the valve also reduces surgical procedure time and the trauma associated with present conventional surgical procedures.   ATS Medical is developing sutureless tissue valve technology

...

NuVasive, Inc. (NUVA) is one of the top-performing Zacks #1 Rank companies on Wednesday with shares that have gained approximately 6.2%.

In late July, NUVA released its second-quarter report, which included better-than-expected EPS and a raised full-year guidance. Earnings estimates remain well above levels from 2 months ago.

The company is part of the Medical Products industry. The Zacks #1 Rank List includes 2 other companies from this space: Hanger Orthopedic Group, Inc. (HGR) and Micrus Endovascular Corporation (MEND).

NUVA is a medical device company focused on the design, development and marketing of products for the surgical treatment of spine disorders. Volume today is about 413,000 shares; above the daily average of 391,000.

Earnings Estimates

The Zacks Consensus Estimate for this year is currently 26 cents per share, marking a 116% surge in the last 2 months from 12 cents per share.

...